Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,100,410 papers from all fields of science
Search
Sign In
Create Free Account
1p/19q Codeletion
Known as:
Loss of Chromosomes 1p/19q
A chromosomal aberration where there is a loss of both the short arm of chromosome 1 and the long arm of chromosome 19. This chromosomal aberration…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Chromosomes, Human, Pair 1
Chromosomes, Human, Pair 19
Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OS11.2 Risk-adjusted survival outcomes for and features of 1p/19q codeletion oligodendrogliomas
B. Iorgulescu
2017
Corpus ID: 80087082
Abstract Background: Oligodendrogliomas (OGs) are diffuse gliomas defined by IDH mutation and 1p/19q codeletion, in which…
Expand
2016
2016
The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients.
P. Hacısalihoğlu
,
Z. Kucukodaci
,
Gokcen Gundogdu
,
B. Bilgiç
Turkish Neurosurgery
2016
Corpus ID: 4484447
AIM To observe the correlation between 1p/19q codeletion, isocytrate dehydrogenase-1 (IDH1) mutation and p53 protein…
Expand
2015
2015
Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p/19q codeletion status
P. Bourdillon
,
C. Hlaihel
,
+4 authors
F. Cotton
Journal of Neuro-Oncology
2015
Corpus ID: 26667788
The aim of this study was to assess whether combining multimodal magnetic resonance imaging (MRI) with the determination of the…
Expand
2015
2015
p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendroglioma.
V. Barresi
,
S. Mondello
,
G. Branca
,
T. S. Rajan
,
E. Vitarelli
,
G. Tuccari
Human Pathology
2015
Corpus ID: 30870459
2015
2015
Radiotherapy in relation to temozolomide: Subgroup analysis of molecular markers of the randomized phase III study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) in patients with a high risk…
B. Baumert
,
M. Hegi
,
+16 authors
R. Stupp
2015
Corpus ID: 79420557
2006 Background: A subgroup analysis based on molecular markers of patients randomized between standard radiotherapy (RT) and…
Expand
2014
2014
Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas.
A. Alentorn
,
H. V. van Thuijl
,
+14 authors
A. Idbaih
Neuro-Oncology
2014
Corpus ID: 10408656
BACKGROUND Diffuse low-grade gliomas (LGGs) form a heterogeneous subgroup of gliomas in adults. Chromosome (chr) arms 1p/19q…
Expand
2013
2013
Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers
G. Minniti
,
A. Arcella
,
+7 authors
R. Enrici
Journal of Neuro-Oncology
2013
Corpus ID: 22593280
Abstract Combination of procarbazine, lomustine and vincristine (PCV) with radiation therapy (RT) has been associated with longer…
Expand
Review
2012
Review
2012
Chemotherapy in low-grade gliomas
A. Viaccoz
,
A. Lekoubou
,
F. Ducray
Current Opinion in Oncology
2012
Corpus ID: 11833988
Purpose of review This review summarizes the recent studies in adults’ diffuse low-grade gliomas (LGGs) chemotherapy, including…
Expand
2011
2011
&agr;-Internexin in the Diagnosis of Oligodendroglial Tumors and Association With 1p/19q Status
S. Eigenbrod
,
S. Roeber
,
+7 authors
H. Kretzschmar
Journal of Neuropathology and Experimental…
2011
Corpus ID: 1256015
&agr;-Internexin (INA) has been proposed to be a surrogate marker for the 1p/19q codeletion in oligodendroglial tumors (OTs). We…
Expand
Review
2010
Review
2010
[Advances in adults' gliomas biology, imaging and treatment].
F. Ducray
,
G. Dutertre
,
D. Ricard
,
E. Gontier
,
A. Idbaih
,
C. Massard
Bulletin du Cancer
2010
Corpus ID: 116560851
A better understanding of gliomas biology is now leading to a combined histo-molecular classification of these tumors. In…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE